Contractor
REGENERON PHARMACEUTICALS INC
TARRYTOWN, NY
- UEI
- N3F9MH7E6HD6
- Parent UEI
- N3F9MH7E6HD6
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$704,343,1041
Awards
3
Agencies served
2
Active from Sep 28, 2017 to Jul 30, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| HHSO100201700016C IGF::OT::IGF | Department of Health and Human Services | NY | Sep 28, 2017 | $695,741,476 |
| 36F79721D0169 FSS | Department of Veterans Affairs | — | Mar 3, 2026 | — |
| HHSO100201600023C REGENERON ANTI-MERS ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT | Department of Health and Human Services | NY | Mar 19, 2026 | $8,601,629 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier N3F9MH7E6HD6, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.